Yolanda K Sanchez

US Patent:

RE40789, Jun 23, 2009

Filed:

Oct 9, 2002

Appl. No.:

10/267717

Inventors:

Stephen J. Elledge - Houston TX, US
Yolanda Sanchez - Cincinnati OH, US

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

C12N 9/12
C12N 9/10
A61K 38/00
C07K 1/00

US Classification:

435194, 435193, 530324, 530326, 530350

Abstract:

The present invention relates to the isolation of gene sequences encoding mammalian cell cycle checkpoints, as well as the expression of the encoded proteins using recombinant DNA technology. The expressed proteins are used to generate specific antibodies and to inhibit the growth of cells. The human checkpoint gene sequences are used as a probe for a portion of the chromosome associated with tumors and other malignancies, as well as growth and/or development deficiencies.

US Patent:

20020156247, Oct 24, 2002

Filed:

Dec 12, 2001

Appl. No.:

10/020038

Inventors:

Stephen Elledge - Houston TX, US
Yolanda Sanchez - Cincinnati OH, US

International Classification:

C07K016/40

US Classification:

530/389100

Abstract:

The present invention relates to the isolation of gene sequences encoding mammalian cell cycle checkpoints, as well as the expression of the encoded proteins using recombinant DNA technology. The expressed proteins are used to generate specific antibodies and to inhibit the growth of cells. The human checkpoint gene sequences are used as a probe for a portion of the chromosome associated with tumors and other malignancies, as well as growth and/or development deficiencies.

US Patent:

63070154, Oct 23, 2001

Filed:

Jan 12, 2000

Appl. No.:

9/488364

Inventors:

Stephen J. Elledge - Houston TX
Yolanda Sanchez - Houston TX

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

A61K 3800

US Classification:

530324

Abstract:

The present invention relates to the isolation of gene sequences encoding mammalian cell cycle checkpoints, as well as the expression of the encoded proteins using recombinant DNA technology. The expressed proteins are used to generate specific antibodies and to inhibit the growth of cells. The human checkpoint gene sequences are used as a probe for a portion of the chromosome associated with tumors and other malignancies, as well as growth and/or development deficiencies.

US Patent:

62181092, Apr 17, 2001

Filed:

Sep 5, 1997

Appl. No.:

8/924183

Inventors:

Stephen J. Elledge - Houston TX
Yolanda Sanchez - Houston TX

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

C12Q 168
C12N 1563
C12N 120
C07H 2104

US Classification:

435 6

Abstract:

The present invention relates to the isolation of gene sequences encoding mammalian cell cycle checkpoints, as well as the expression of the encoded proteins using recombinant DNA technology. The expressed proteins are used to generate specific antibodies and to inhibit the growth of cells. The human checkpoint gene sequences are used as a probe for a portion of the chromosome associated with tumors and other malignancies, as well as growth and/or development deficiencies.